Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Oropharyngeal Neoplasms × durvalumab × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 29 Lung Neoplasms 9 Small Cell Lung Carcinoma 7 Biliary Tract Neoplasms 7 Carcinoma, Hepatocellular 5 Urinary Bladder Neoplasms 4 Liver Neoplasms 4 Carcinoma 4 Small Cell Lung Carcinoma Extensive Disease 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Gallbladder Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urothelial Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Pancoast Syndrome 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Small Cell Lung Carcinoma NSCLC 1 Non Small Cell Lung Cancer NSCLC 1 Non - Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1

Interventions

Cisplatin 6 Radiotherapy 5 Radiotherapy, Intensity-Modulated 3 Magnetic Resonance Spectroscopy 3 Carboplatin 3 Taxes 2 Specimen Handling 2 Platinum 2 Paclitaxel 2 Observation 2 Fluorouracil 2 1,2-diaminocyclohexaneplatinum II citrate 2 pembrolizumab 1 durvalumab 1 dehydroftorafur 1 Watchful Waiting 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sucralfate 1 Standard of Care 1 Salts 1 Radiation 1 Nivolumab 1 Gabapentin 1 Fluorodeoxyglucose F18 1 Drug Therapy 1 Dexamethasone 1 Chemoradiotherapy 1 Cetuximab 1 (225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116047 2024-07-29

CompARE

University of Birmingham

Phase 3 Active not recruiting

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡